AG
BMY icon

Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History

Advisor Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$16.3M Buy
253,647
+38,046
+18% +$2.18M 0.11% 164
2019
Q3 		$10.9M Buy
215,601
+740
+0.3% +$34.8K 0.08% 216
2019
Q2 		$9.75M Sell
214,861
-6,489
-3% -$302K 0.07% 231
2019
Q1 		$10.6M Buy
221,350
+15,137
+7% +$754K 0.09% 201
2018
Q4 		$10.7M Buy
206,213
+51,686
+33% +$2.78M 0.11% 169
2018
Q3 		$9.6M Buy
154,527
+21,668
+16% +$1.29M 0.1% 187
2018
Q2 		$7.35M Sell
132,859
-2,854
-2% -$154K 0.1% 182
2018
Q1 		$8.59M Sell
135,713
-12,415
-8% -$799K 0.12% 163
2017
Q4 		$9.08M Buy
148,128
+7,740
+6% +$484K 0.12% 161
2017
Q3 		$8.95M Buy
140,388
+11,458
+9% +$669K 0.14% 144
2017
Q2 		$7.18M Buy
128,930
+2,719
+2% +$148K 0.13% 162
2017
Q1 		$6.86M Buy
126,211
+4,148
+3% +$228K 0.14% 160
2016
Q4 		$7.13M Sell
122,063
-6,639
-5% -$363K 0.16% 138
2016
Q3 		$6.94M Buy
128,702
+14,914
+13% +$958K 0.17% 132
2016
Q2 		$8.36M Buy
+113,788
New +$8.04M 0.22% 104

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisor Group's BMY Position: Q4 2019 in Review

Advisor Group increased its Bristol-Myers Squibb (BMY) stake by 18% in Q4 2019, buying an estimated $2.18M and bringing the position to 253,647 shares worth $16.3M. The position accounts for 0.11% of the portfolio, ranked #164.

Advisor Group first reported a position in BMY in Q2 2016 and has held it in 15 quarters since. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Advisor Group held 253,647 shares of Bristol-Myers Squibb worth $16.3M as of Q4 2019.
  • Advisor Group bought 38,046 Bristol-Myers Squibb shares in Q4 2019, an estimated $2.18M.
  • Bristol-Myers Squibb made up 0.11% of Advisor Group's portfolio in Q4 2019, its #164 holding.
  • Advisor Group first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 15 quarters since.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.